BAXTER INTERNATIONAL INC (1BAX.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1BAX - US0718131099 - Common Stock
30.905 EUR
+0.18 (+0.57%)
Overall 1BAX gets a fundamental rating of 3 out of 10. We evaluated 1BAX against 65 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of 1BAX have multiple concerns. 1BAX is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year 1BAX was profitable.
1BAX had a positive operating cash flow in the past year.
In multiple years 1BAX reported negative net income over the last 5 years.
In the past 5 years 1BAX always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of -2.52%, 1BAX is in line with its industry, outperforming 40.35% of the companies in the same industry.
The Return On Equity of 1BAX (-9.32%) is comparable to the rest of the industry.
1BAX's Return On Invested Capital of 3.45% is in line compared to the rest of the industry. 1BAX outperforms 49.12% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1BAX is significantly below the industry average of 9.71%.
The last Return On Invested Capital (3.45%) for 1BAX is above the 3 year average (3.20%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.52% | ||
| ROE | -9.32% | ||
| ROIC | 3.45% |
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.2%
ROIC(5y)4.54%
1.3 Margins
The Operating Margin of 1BAX (7.67%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of 1BAX has declined.
Looking at the Gross Margin, with a value of 38.01%, 1BAX is doing worse than 71.93% of the companies in the same industry.
1BAX's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.67% | ||
| PM (TTM) | N/A | ||
| GM | 38.01% |
OM growth 3Y-25.59%
OM growth 5Y-17.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1BAX is destroying value.
Compared to 1 year ago, 1BAX has more shares outstanding
The number of shares outstanding for 1BAX has been increased compared to 5 years ago.
1BAX has a worse debt/assets ratio than last year.
2.2 Solvency
1BAX has an Altman-Z score of 2.10. This is not the best score and indicates that 1BAX is in the grey zone with still only limited risk for bankruptcy at the moment.
1BAX has a Altman-Z score (2.10) which is comparable to the rest of the industry.
The Debt to FCF ratio of 1BAX is 22.91, which is on the high side as it means it would take 1BAX, 22.91 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 22.91, 1BAX is in line with its industry, outperforming 50.88% of the companies in the same industry.
1BAX has a Debt/Equity ratio of 1.79. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.79, 1BAX is not doing good in the industry: 82.46% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.79 | ||
| Debt/FCF | 22.91 | ||
| Altman-Z | 2.1 |
ROIC/WACC0.53
WACC6.49%
2.3 Liquidity
A Current Ratio of 1.36 indicates that 1BAX should not have too much problems paying its short term obligations.
1BAX has a Current ratio of 1.36. This is comparable to the rest of the industry: 1BAX outperforms 45.61% of its industry peers.
A Quick Ratio of 1.05 indicates that 1BAX should not have too much problems paying its short term obligations.
1BAX has a Quick ratio (1.05) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.37% over the past year.
Measured over the past years, 1BAX shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.21% on average per year.
1BAX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.21%.
1BAX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.31% yearly.
EPS 1Y (TTM)0.37%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-34.09%
Revenue 1Y (TTM)-13.21%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-29.14%
3.2 Future
Based on estimates for the next years, 1BAX will show a small growth in Earnings Per Share. The EPS will grow by 6.87% on average per year.
Based on estimates for the next years, 1BAX will show a small growth in Revenue. The Revenue will grow by 5.61% on average per year.
EPS Next Y-7.17%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
EPS Next 5Y6.87%
Revenue Next Year6.13%
Revenue Next 2Y5.12%
Revenue Next 3Y4.71%
Revenue Next 5Y5.61%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 12.61, 1BAX is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of 1BAX indicates a rather cheap valuation: 1BAX is cheaper than 89.47% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.39. 1BAX is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 13.58 indicates a correct valuation of 1BAX.
Based on the Price/Forward Earnings ratio, 1BAX is valued a bit cheaper than 75.44% of the companies in the same industry.
1BAX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.84, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.61 | ||
| Fwd PE | 13.58 |
4.2 Price Multiples
78.95% of the companies in the same industry are more expensive than 1BAX, based on the Enterprise Value to EBITDA ratio.
1BAX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. 1BAX is cheaper than 73.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.59 | ||
| EV/EBITDA | 13.5 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.96%
EPS Next 3Y3.75%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.17%, 1BAX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.03, 1BAX pays a better dividend. On top of this 1BAX pays more dividend than 80.70% of the companies listed in the same industry.
1BAX's Dividend Yield is comparable with the S&P500 average which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.17% |
5.2 History
On average, the dividend of 1BAX grows each year by 6.89%, which is quite nice.
Dividend Growth(5Y)6.89%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
1BAX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of 1BAX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-90.91%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
BIT:1BAX (3/26/2025, 7:00:00 PM)
30.905
+0.18 (+0.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.07%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap15.85B
Revenue(TTM)12.86B
Net Income(TTM)-649.00M
Analysts68.18
Price Target35.44 (14.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.17% |
Yearly Dividend1.05
Dividend Growth(5Y)6.89%
DP-90.91%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.32%
Min EPS beat(2)1.94%
Max EPS beat(2)10.69%
EPS beat(4)4
Avg EPS beat(4)5.06%
Min EPS beat(4)1.64%
Max EPS beat(4)10.69%
EPS beat(8)7
Avg EPS beat(8)3.73%
EPS beat(12)8
Avg EPS beat(12)2.99%
EPS beat(16)12
Avg EPS beat(16)4.13%
Revenue beat(2)1
Avg Revenue beat(2)0.5%
Min Revenue beat(2)-0.93%
Max Revenue beat(2)1.93%
Revenue beat(4)3
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)1.93%
Revenue beat(8)4
Avg Revenue beat(8)-0.57%
Revenue beat(12)4
Avg Revenue beat(12)-1.99%
Revenue beat(16)5
Avg Revenue beat(16)-2.54%
PT rev (1m)-3.81%
PT rev (3m)-3.81%
EPS NQ rev (1m)-31.48%
EPS NQ rev (3m)-31.48%
EPS NY rev (1m)-22.05%
EPS NY rev (3m)-22.05%
Revenue NQ rev (1m)-30.35%
Revenue NQ rev (3m)-30.35%
Revenue NY rev (1m)-28.82%
Revenue NY rev (3m)-28.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.61 | ||
| Fwd PE | 13.58 | ||
| P/S | 1.36 | ||
| P/FCF | 30.59 | ||
| P/OCF | 17.2 | ||
| P/B | 2.52 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.5 |
EPS(TTM)2.45
EY7.93%
EPS(NY)2.28
Fwd EY7.36%
FCF(TTM)1.01
FCFY3.27%
OCF(TTM)1.8
OCFY5.81%
SpS22.67
BVpS12.28
TBVpS-6.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.52% | ||
| ROE | -9.32% | ||
| ROCE | 5.12% | ||
| ROIC | 3.45% | ||
| ROICexc | 3.76% | ||
| ROICexgc | 8.07% | ||
| OM | 7.67% | ||
| PM (TTM) | N/A | ||
| GM | 38.01% | ||
| FCFM | 4.46% |
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.2%
ROIC(5y)4.54%
ROICexc(3y)3.57%
ROICexc(5y)5.33%
ROICexgc(3y)9.57%
ROICexgc(5y)12.38%
ROCE(3y)4.43%
ROCE(5y)6.16%
ROICexgc growth 3Y-30.34%
ROICexgc growth 5Y-21.96%
ROICexc growth 3Y-22.52%
ROICexc growth 5Y-26.32%
OM growth 3Y-25.59%
OM growth 5Y-17.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
F-Score3
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.79 | ||
| Debt/FCF | 22.91 | ||
| Debt/EBITDA | 6.3 | ||
| Cap/Depr | 44.73% | ||
| Cap/Sales | 3.47% | ||
| Interest Coverage | 4.42 | ||
| Cash Conversion | 51.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 2.1 |
F-Score3
WACC6.49%
ROIC/WACC0.53
Cap/Depr(3y)49.31%
Cap/Depr(5y)63.51%
Cap/Sales(3y)5.12%
Cap/Sales(5y)5.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.37%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-34.09%
EPS Next Y-7.17%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
EPS Next 5Y6.87%
Revenue 1Y (TTM)-13.21%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-29.14%
Revenue Next Year6.13%
Revenue Next 2Y5.12%
Revenue Next 3Y4.71%
Revenue Next 5Y5.61%
EBIT growth 1Y-21.12%
EBIT growth 3Y-30.01%
EBIT growth 5Y-18.5%
EBIT Next Year69.69%
EBIT Next 3Y22.35%
EBIT Next 5Y25.92%
FCF growth 1Y-44.58%
FCF growth 3Y-27.1%
FCF growth 5Y-16.46%
OCF growth 1Y-40.96%
OCF growth 3Y-22.88%
OCF growth 5Y-13.5%
BAXTER INTERNATIONAL INC / 1BAX.MI FAQ
What is the ChartMill fundamental rating of BAXTER INTERNATIONAL INC (1BAX.MI) stock?
ChartMill assigns a fundamental rating of 3 / 10 to 1BAX.MI.
What is the valuation status for 1BAX stock?
ChartMill assigns a valuation rating of 5 / 10 to BAXTER INTERNATIONAL INC (1BAX.MI). This can be considered as Fairly Valued.
What is the profitability of 1BAX stock?
BAXTER INTERNATIONAL INC (1BAX.MI) has a profitability rating of 3 / 10.
What are the PE and PB ratios of BAXTER INTERNATIONAL INC (1BAX.MI) stock?
The Price/Earnings (PE) ratio for BAXTER INTERNATIONAL INC (1BAX.MI) is 12.61 and the Price/Book (PB) ratio is 2.52.
How financially healthy is BAXTER INTERNATIONAL INC?
The financial health rating of BAXTER INTERNATIONAL INC (1BAX.MI) is 3 / 10.